132 related articles for article (PubMed ID: 9802837)
1. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization.
Akiyama K; Ujike H; Sakai K; Shimizu Y; Kodama M; Kuroda S
Pharmacol Biochem Behav; 1998 Dec; 61(4):419-26. PubMed ID: 9802837
[TBL] [Abstract][Full Text] [Related]
2. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
[TBL] [Abstract][Full Text] [Related]
3. AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice.
Jackson A; Mead AN; Rocha BA; Stephens DN
Behav Pharmacol; 1998 Sep; 9(5-6):457-67. PubMed ID: 9832931
[TBL] [Abstract][Full Text] [Related]
4. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice.
Itzhak Y; Martin JL
Psychopharmacology (Berl); 2000 Aug; 151(2-3):226-33. PubMed ID: 10972469
[TBL] [Abstract][Full Text] [Related]
5. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
Maj J; Rogóz Z; Skuza G; Jaros T
Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
Massieu L; Tapia R
Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
[TBL] [Abstract][Full Text] [Related]
7. AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis.
Sakai K; Akiyama K; Kashihara K; Tsuchida K; Ujike H; Kuroda S; Shohmori T
Neurochem Int; 1997 Mar; 30(3):329-36. PubMed ID: 9041565
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
9. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
DeGiorgio LA; DeGiorgio N; Volpe BT
Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
[TBL] [Abstract][Full Text] [Related]
10. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
[TBL] [Abstract][Full Text] [Related]
12. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
[TBL] [Abstract][Full Text] [Related]
13. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline (NBQX) increases fibroblast growth factor mRNA levels after contusive spinal cord injury.
Follesa P; Wrathall JR; Mocchetti I
Brain Res; 1998 Jan; 782(1-2):306-9. PubMed ID: 9519278
[TBL] [Abstract][Full Text] [Related]
14. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
Hu P; Diemer NH; Bruhn T; Johansen FF
J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
[TBL] [Abstract][Full Text] [Related]
15. AMPA receptor competitive antagonism reduces halothane MAC in rats.
McFarlane C; Warner DS; Todd MM; Nordholm L
Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
[TBL] [Abstract][Full Text] [Related]
17. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
18. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
Pollack AE; St Martin JL; MacPherson AT
Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion.
Rosenberg LJ; Teng YD; Wrathall JR
J Neurosci; 1999 Jan; 19(1):464-75. PubMed ID: 9870974
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cardiorespiratory parameters in rats after spinal cord trauma and treatment with NBQX, an antagonist of excitatory amino acid receptors.
Teng YD; Wrathall JR
Neurosci Lett; 1996 May; 209(1):5-8. PubMed ID: 8734896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
